A theobromine carboxylic acid cocrystal and its preparation method and application
By forming eutectics with different carboxylic acids, the problem of low solubility of cocoa alkali is solved, and its solubility in water and PBS is significantly improved, and the absorption and bioavailability of drugs are improved.
Patent Information
- Application Number
- CN202310461243.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-04-23
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2043-04-23
AI Technical Summary
In the prior art, the solubility of insoluble drugs such as cocoa base is low, which affects its absorption and bioavailability in the body.
The solubility of the cocoa base is improved by forming eutectics with carboxylic acids such as paracoumaric acid, 2,4,6-trihydroxybenzoic acid, gallic acid, 1-hydroxy-2-naphtholic acid, succinic acid and citric acid.
The solubility of cocoa alkali in water and PBS was significantly improved, and the solubility of eutectic TBR-GAL·4H2O and TBR-p-COA was increased by 1.88 times and 2.98 times, respectively, improving the absorption and bioavailability of drugs.
Smart Images

Figure CN116554173B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of cocrystals, and in particular relates to a theobromine carboxylic acid cocrystal and a preparation method and application thereof. Background Art
[0002] The information disclosed in this background technology section is only intended to enhance the understanding of the overall background of the invention, and should not necessarily be regarded as an admission or any form of suggestion that the information constitutes the prior art already known to a person skilled in the art.
[0003] Improving the solubility of poorly soluble drugs is a difficult problem in the current pharmaceutical field and development process, as low solubility will affect human absorption. Currently, most salt drugs on the market are prepared to improve solubility, but there are many limitations in the preparation of salt drugs. First, the transfer of protons during salt formation may affect the pharmacological properties of the drug. Secondly, the selection of salt-forming ligands needs to be non-toxic and pharmaceutically acceptable, and there are few acids and bases that can form salts. Finally, the formation of salts requires at least one ionization center in the active pharmaceutical ingredient (API), and APIs without ionization centers cannot form salts.
[0004] Pharmaceutical cocrystals refer to crystals formed by the combination of active pharmaceutical ingredients and cocrystal formers (CCFs) in a fixed stoichiometry under the action of non-covalent bonds, which can adjust the different physical and chemical properties of drugs without changing the pharmacological properties of drugs. Its pharmaceutical applications also include regulating solubility and dissolution, thereby improving in vivo absorption and bioavailability, and promoting the development and application of Class II drugs in the Biomedical Classification System (BCS). Therefore, cocrystals have received great attention in the fields of medicine and so on. Cocrystals do not undergo proton transfer, but are combined together through supramolecular interactions and a wide range of ligand selections. The types of APIs that form cocrystals are not restricted, and CCFs such as pharmaceutical excipients, commonly used salt-forming ligands, and food additives can be selected.
[0005] Theobromine (TBR) is a xanthine derivative that is similar in structure to caffeine and theophylline and has central nervous system effects. It can also be used as a phosphodiesterase inhibitor, weak adenosine receptor antagonist, smooth muscle relaxant, etc. Theobromine is difficult to administer orally due to its low solubility and slow dissolution rate, which limits the research and development of related products. Summary of the invention
[0006] In order to solve the deficiencies of the prior art, the purpose of the present invention is to provide a theobromine carboxylic acid cocrystal and a preparation method and application thereof. The present invention provides a cocrystal formed by theobromine and p-coumaric acid (p-COA), 2,4,6-trihydroxybenzoic acid (2,4,6-TRM), gallic acid (GAL), 1-hydroxy-2-naphthoic acid (1-H-2-NA), succinic acid (SCA) and citric acid (CAM), and the solubility of the obtained cocrystal is improved relative to that of theobromine, and the solubility of the cocrystal TBR-GAL·4H2O and TBR-p-COA in water and in PBS is increased by 1.88 times and 2.98 times, respectively.
[0007] In order to achieve the above object, the present invention is implemented through the following technical solutions:
[0008] In a first aspect, the present invention provides a theobromine carboxylic acid co-crystal, wherein the theobromine carboxylic acid co-crystal is formed by theobromine and a carboxylic acid, wherein the carboxylic acid is one of p-coumaric acid, 2,4,6-trihydroxybenzoic acid, gallic acid, 1-hydroxy-2-naphthoic acid, succinic acid and citric acid.
[0009] In a second aspect, the present invention provides a method for preparing theobromine carboxylic acid cocrystal according to the first aspect, comprising a solvent-assisted grinding method or a solvent volatilization method.
[0010] In a third aspect, the present invention provides use of the theobromine carboxylic acid cocrystal described in the first aspect in the preparation of a theobromine-containing medicine or food.
[0011] The beneficial effects achieved by one or more technical solutions of the present invention are as follows:
[0012] The present invention constructs cocrystals formed by theobromine and p-coumaric acid, 2,4,6-trihydroxybenzoic acid, gallic acid, 1-hydroxy-2-naphthoic acid, succinic acid and citric acid, reports two non-dissolving single crystals (TBR-2,4,6-TRM, TBR-p-COA) and one hydrate single crystal (TBR-GAL·4H2O) for the first time, and confirms the structures of the cocrystals and single crystals.
[0013] The formation of theobromine carboxylic acid cocrystal in the present invention is mainly determined by the hydrogen bond network between TBR and carboxylic acid, and TBR-GAL·2H2O and TBR-GAL·4H2O are mainly stabilized by water molecules.
[0014] Theobromine carboxylic acid cocrystals significantly affect the solubility of TBR. Except for TBR-1-H-2-NA, the equilibrium solubility of the cocrystals in pure water and PBS shows an increase in solubility. The solubility of the cocrystals TBR-GAL·4H2O and TBR-p-COA in water and in PBS increased by 1.88 times and 2.98 times, respectively. BRIEF DESCRIPTION OF THE DRAWINGS
[0015] The accompanying drawings in the specification, which constitute a part of the present invention, are used to provide a further understanding of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute improper limitations on the present invention.
[0016] Figure 1 Schematic diagram of the structural unit (a) and 1D sheet structure (b) of TBR-p-COA with hydrogen bond atom labels;
[0017] Figure 2 Schematic diagram of the asymmetric unit structure of TBR-2,4,6-TRM (a), the polymer chain composed of alternating hydrogen-bonded TBR and 2,4,6-TRM molecules (b), the 2D structure in the C-axis direction (c), and the 3D structure (d);
[0018] Figure 3 Schematic diagram of the asymmetric unit, 2D structure (b), and 3D structure (c) of TBR-GAL·2H2O with hydrogen-bonded atom labels;
[0019] Figure 4 Schematic diagram of the structural unit (a), 2D structure (b), and 3D structure (c) of TBR-GAL·4H2O with hydrogen-bonded atoms labeled;
[0020] Figure 5 PXRD diffraction data and simulated SCXRD data diagrams of TBR-2,4,6-TRM, TBR-p-COA, TBR-GAL·2H2O and TBR-GAL·4H2O;
[0021] Figure 6 PXRD patterns of TBR-1-H-2-NA and 1-H-2-NA (a), TBR-CAM and (b), TBR-SCA and SCA (c);
[0022] Figure 7 DSC-TGA curves of TBR-p-COA (A), TBR-2,4,6-TRM (B), TBR-GAL·2H2O (C), TBR-GAL·4H2O (D), TBR-SCA (E), TBR-CAM (F), TBR-1-H-2-NA (G), and TBR (H). The curve that intersects the left ordinate axis at 100 is the TGA curve;
[0023] Figure 8 DSC-TGA curves of p-COA (A), 2,4,6-TRM (B), GAL (C), SCA (D), CAM (E), and 1-H-2-NA (F), and the curve intersecting the left ordinate axis at 100 is the TGA curve;
[0024] Fig. 9 Infrared spectra of TBR-p-COA (a), TBR-2,4,6-TRM (b), TBR-GAL·2H2O (c), TBR-GAL·4H2O (d), TBR (e), TBR-CAM (f), TBR-1-H-2-NA (g) and TBR-SCA (h). DETAILED DESCRIPTION
[0025] The first typical embodiment of the present invention is a theobromine carboxylic acid cocrystal, wherein the theobromine carboxylic acid cocrystal is formed by theobromine and a carboxylic acid, wherein the carboxylic acid is one of p-coumaric acid, 2,4,6-trihydroxybenzoic acid, gallic acid, 1-hydroxy-2-naphthoic acid, succinic acid and citric acid.
[0026] In one or more examples of this embodiment, the molar ratio of theobromine to carboxylic acid is 1:1 or 2:1.
[0027] According to a second typical embodiment of the present invention, the method for preparing theobromine carboxylic acid cocrystal described in the first typical embodiment comprises a solvent-assisted grinding method or a solvent volatilization method.
[0028] In one or more examples of this implementation mode, the solvent-assisted grinding method is specifically: mixing theobromine, carboxylic acid and acetone in a ball mill, and obtaining theobromine carboxylic acid cocrystals after ball milling.
[0029] In one or more examples of this embodiment, the molar ratio of theobromine to carboxylic acid is 1-2:1.
[0030] In one or more examples of this embodiment, the ball milling frequency is 15-30 Hz, and the ball milling time is 30-60 min.
[0031] In one or more examples of this implementation mode, the solvent volatilization method is specifically: theobromine and carboxylic acid are mixed and dissolved in a solvent, and the solvent is evaporated to obtain theobromine carboxylic acid cocrystal.
[0032] In one or more examples of this embodiment, the molar ratio of theobromine to carboxylic acid is 1-2:1.
[0033] In one or more examples of this embodiment, the solvent includes one or a mixture of methanol, ethanol, water, and acetonitrile.
[0034] A third typical embodiment of the present invention is the use of the theobromine carboxylic acid cocrystal described in the first typical embodiment in the preparation of a medicine or food containing theobromine.
[0035] In order to enable those skilled in the art to more clearly understand the technical solution of the present invention, the technical solution of the present invention will be described in detail below in combination with specific embodiments and comparative examples.
[0036] Example 1
[0037] 0.50 mmol TBR and 0.25 mmol CAM were mixed with 40 μL acetone in a 5 mL ball mill and ground with two 7 mm stainless steel balls at a frequency of 20 Hz for 30 min to obtain the co-crystal TBR-CAM.
[0038] Example 2
[0039] 0.25 mmol TBR and 0.25 mmol 2,4,6-TRM were mixed with 30 L methanol in a 5 mL ball mill and ground with two 7 mm stainless steel balls at a frequency of 20 Hz for 30 min to obtain the co-crystal TBR-2,4,6-TRM.
[0040] Example 3
[0041] 0.25 mmol TBR and 0.25 mmol p-COA were mixed with 30 L methanol in a 5 mL ball mill and ground with two 7 mm stainless steel balls at a frequency of 20 Hz for 30 min to obtain co-crystal TBR-p-COA.
[0042] Example 4
[0043] At 20°C, 0.25 mmol TBR and 0.25 mmol GAL were dissolved in a total volume of 14 mL of a mixed solvent of methanol, ethanol and water (volume ratio of methanol / ethanol / water = 15:15:1), heated at 70°C, stirred and filtered, and the solvent was evaporated at 20°C to obtain a TBR-GAL·2H2O eutectic single crystal.
[0044] Example 5
[0045] At 20°C, 0.25 mmol TBR and 0.25 mmol GAL were dissolved in a total volume of 14 mL of a mixed solvent of methanol, acetonitrile and water (volume ratio of methanol / acetonitrile / water = 15:15:1), heated at 70°C, stirred and filtered, and the solvent was evaporated at 20°C to obtain a TBR-GAL·4H2O eutectic single crystal.
[0046] Example 6
[0047] At 20°C, 0.25 mmol TBR and 0.25 mmol p-COA were dissolved in a total volume of 14 mL of a mixed solvent of methanol and water (volume ratio of methanol / water = 1:1), heated at 70°C, stirred and filtered, and the solvent was evaporated at 20°C to obtain a TBR-p-COA eutectic single crystal.
[0048] Example 7
[0049] At 20°C, 0.25 mmol TBR and 0.25 mmol 2,4,6-TRM were dissolved in 14 mL acetonitrile, heated at 70°C, stirred, and filtered, and the solvent was evaporated at 20°C to obtain a TBR-2,4,6-TRM cocrystal single crystal.
[0050] Example 8
[0051] A mixture of 2.5 mmol TBR and 2.5 mmol 2,4,6-TRM was dissolved in 140 mL acetonitrile. The solution was heated and stirred for 4 h, filtered, and the filtrate was evaporated in a vacuum oven to obtain co-crystal TBR-CAM.
[0052] Example 9
[0053] A mixture of 0.3.5 mmol TBR and 1.75 mmol SCA was dissolved in 140 mL acetonitrile. The solution was heated and stirred for 4 h, filtered, and the filtrate was evaporated in a vacuum oven to obtain co-crystal TBR-SCA.
[0054] Example 10
[0055] A mixture of 2.5 mmol TBR and 2.5 mmol 1-H-2-NA was dissolved in 140 mL acetonitrile. The solution was heated and stirred for 4 h, filtered, and the filtrate was evaporated in a vacuum oven to obtain cocrystal TBR-1-H-2-NA.
[0056] Embodiment 11
[0057] Figure 1 Figure a shows a supramolecular synthon (cocrystal monomer) of cocrystal multiple hydrogen bonds formed by one TBR molecule and one p-COA molecule. The NH group on the pyrimidine ring of TBR is a good proton donor, while the two carbonyl oxygen atoms and the imidazole nitrogen atom are good acceptors. The carbonyl group on TBR forms a hydrogen bond with the hydrogen on the carboxyl group of p-COA (O5-H5···O1), and the carbonyl oxygen atom on the carboxyl group of p-COA forms a hydrogen bond with the hydrogen on the pyrimidine ring of TBR (N2-H2···O4). This is a relatively stable form of hydrogen bonding. The hydroxyl group in p-COA provides a proton donor for the amino group of TBR (O3-H3···N4), and the groups are connected by hydrogen bonds to form a 1D chain, such as Figure 1 As shown in b.
[0058] TBR-2,4,6-TRM crystallizes in the monoclinic P21 / c space group. Figure 2 As shown in a in Figure 1, there is one TBR molecule and one 2,4,6-TRM molecule in the asymmetric unit of TBR-2,4,6-TRM. Figure 2As shown in Figure b, TBR and 2,4,6-TRM form a 1D linear polymer chain in a stoichiometric ratio of 1:1. There are two strong intramolecular hydrogen bonds in the 2,4,6-TRM molecule, namely O3-H3···O2 and O7-H7···O4. Figure 2 As shown in d, the TBR molecule and 2,4,6-TRM are bonded to each other through hydrogen bonds O4-H4···N3. The NH group on the pyrimidine ring of TBR provides a proton donor for the hydroxyl group in the acid (N2-H2···O1), and it is also a proton donor for the carbonyl group inside the TBR molecule (O1-H1···O6). Figure 2 As shown in (c), the two polymer chains are tilted at an angle and stabilized by π(TBR)-π(2,4,6-TRM) forces.
[0059] In the study of TBR and GAL cocrystals, two different crystal structures were obtained under different conditions. One is a monoclinic space group C2 / c crystal containing two water molecules, and the other is a monoclinic space group C2 / c crystal containing four water molecules. The crystal structure of TBR-GAL·2H2O shows a dihydrate cocrystal. Figure 3 As shown in a in the figure, the asymmetric unit of TBR-GAL·2H2O consists of one TBR molecule, one GAL molecule and two water molecules. Water molecules also play a very important role in the formation of the crystal structure because they can be hydrogen bond acceptors or donors. The hydroxyl group in the carboxylic acid provides a proton to the carbonyl oxygen atom on the pyrimidine ring of TBR to form an O4-H4···O6 hydrogen bond. At the same time, the hydroxyl group in the carboxylic acid also acts as an acceptor for water molecules (O7-H7···O4). The two hydrogen bonds O1-H1A···O7 and O8-H8···O9 in the hydroxyl group of the carboxylic acid provide protons to two water molecules respectively. A double bond is also formed between TBR and carboxylic acid (N1-H1···O5, O3-H3···O6). The carbonyl oxygen atom on the pyrimidine ring of TBR and the imidazole nitrogen atom are proton acceptors for water molecules. As shown in Figure 3 As shown in (b), the 2D structure is formed by hydrogen bonds between water molecules, TBR and carboxylic acid. Figure 3 As shown in (c), the one-dimensional polymer system is arranged in “stairs” and forms a three-dimensional network through π-π interactions.
[0060] like Figure 4 As shown in a, there is one TBR molecule, one GAL molecule, and four H2O molecules in the asymmetric unit of TBR-GAL·4H2O. Like TBR-GAL·2H2O, TBR and GAL also have a double bond (N3-H3···O6, O12-H12···O4). The nitrogen atom on the imidazole ring of TBR forms a hydrogen bond O8-H8···N2 with the hydrogen atom on the hydroxyl group of the carboxylic acid, so the chain is formed on a single plane through the hydrogen bond between TBR and the carboxylic acid, as shown in FIG. Figure 4 As shown in b in Figure 1, water molecules are good acceptors and good donors. TBR and carboxylic acid form hydrogen bonds with water molecules as shown in Figure 1. Figure 4 The three-dimensional structure shown in c. The two carbonyl groups on the pyrimidine ring of TBR can form hydrogen bonds with two water molecules (O13-H13E···O4, O3-H3B···O1). The hydroxyl group on the carboxylic acid provides a hydrogen atom to the water molecule (O7-H7···O3).
[0061] The crystallographic data of TRM-p-COA, TBR-2,4,6-TRM, TBR-GAL·2H2O and TBR-GAL·4H2O are shown in Table 1 , and the hydrogen bonding parameters and symmetry codes are shown in Table 2 .
[0062] Table 1 Crystallographic data of TRM-p-COA, TBR-2,4,6-TRM, TBR-GAL·2H2O and TBR-GAL·4H2O
[0063]
[0064]
[0065]
[0066] Table 2 Hydrogen bond distances and parameters of TRM-p-COA, TBR-2,4,6-TRM, TBR-GAL·2H2O and TBR-GAL·4H2O
[0067]
[0068]
[0069]
[0070] Example 12
[0071] Powder X-ray diffraction (PXRD) measurements were performed using a MiniFlex600 powder diffractometer (Rigaku) with the following experimental parameters: tube voltage and current set to 40 kV and 30 mA; Cu Kα radiation (0.15405 nm) in the 2θ range (3–50°) at room temperature. The step size was 0.02 and the scan speed was 8° / min. The experimental PXRD patterns of the single crystal structures were compared with the calculated PXRD patterns to confirm the composition of the powder material.
[0072] Single crystals of TBR-2,4,6-TRM, TBR-p-COA, TBR-GAL·2H2O and TBR-GAL·4H2O with appropriate size were selected under an optical microscope and quickly coated with high vacuum grease (Dow Corning) to prevent decomposition. Crystals were mounted on a CryoLoopTM ring and cell parameters and intensity data were recorded on a Riga Ku Oxford Diffraction XtaLAB Synergy-S diffractometer equipped with a HyPix-6000HE hybrid photon counting (HPC) detector operated in shutterless mode and processed using the CrystAlisPro software suite at 100 K using Cu Kα (λ = 1.54184) for TBR-2,4,6-TRM, TBR-p-COA, TBR-GAL·2H2O and TBR-GAL·4H2O from a PhotonJet micro-focus. The structures were solved using the charge-flipping algorithm implemented in the program SUPERFLIP and the Fo2 was optimized by a full-matrix least-squares technique using the SHELXL program3 via the OLEX2 interface.
[0073] like Figure 5 The diffraction peaks of TBR-p-COA cocrystals are shown at 8.1°, 11.5°, 12.4°, 15.8°, 19.7°, and 23.0°; the characteristic peaks of TBR-2,4,6-TRM cocrystals are shown at 5.9°, 12.0°, 15.1°, 26.3°, and 26.7°; the characteristic peaks of TBR-GAL·2H2O cocrystals are shown at 6.4°, 12.0°, 12.8°, 26.1°, and 27.5°; the characteristic peaks of TBR-GAL·4H2O cocrystals are shown at 6.8°, 9.4°, 11.1°, 13.6°, 17.6°, and 25.8°. The PXRD diffraction of the sample experiment is in good agreement with the simulated pattern of the single crystal X-ray diffraction (SCXRD) data, further confirming the formation of high crystallinity cocrystals.
[0074] The XRD patterns of TBR, SCA, CAM, 1-H-2-NA, TBR-SCA, TBR-CAM and TBR-1-H-2-NA are shown in Figure 6 Compared with TBR and carboxylic acid, the characteristic peaks of the co-crystals have changed significantly, which can prove that a new phase is generated rather than a physical mixture.
[0075] Example 13
[0076] DSC-TGA analysis was performed using a TGA / DSC 3+ (Mettler Toledo, Switzerland). The samples were placed in a ceramic crucible and inserted into a TG furnace. The analysis was started at 303.15 K and heated at 10 K min under nitrogen. -1 The furnace is heated at a rate of 1.5 % until the final temperature reaches 623.15 K.
[0077] The DSC-TGA analysis results of TBR-p-COA, TBR-2,4,6-TRM, TBR-GAL·2H2O, TBR-GAL·4H2O, TBR-CAM, TBR-SCA, TBR-1-H-2-NA and TBR are shown in Figure 7 The DSC-TGA analysis results of p-COA, 2,4,6-TRM, GAL, CAM, SCA and 1-H-2-NA are shown in Figure 8 As shown. The TG curves show that TBR-p-COA, TBR-2,4,6-TRM, TBR-GAL·2H2O, TBR-GAL·4H2O and TBR-1-H-2-NA cocrystals decompose when heated to about 197°C, 158°C, 180°C, 204°C and 164°C, respectively, and there is no weight loss before the decomposition temperature. Two obvious endothermic peaks can be seen on the DSC curve. The first endothermic peak represents the decomposition of the ligand, and the second represents the decomposition of TBR, and the temperature is about 300°C. The DSC curves show that before decomposition, TBR-p-COA, TBR-2,4,6-TRM, TBR-GAL·2H2O, TBR-GAL·4H2O, TBR-SCA and TBR-1-H-2-NA eutectics have no melting endotherms, and the endothermic temperatures during decomposition are 217.36℃, 175.48℃, 264.76℃, 259.21℃, 179.77℃, and 191.90℃. When heated to about 150℃, the TBR-CAM eutectic begins to decompose, and there is no weight loss before this temperature. The DSC curve shows that the TBR-CAM eutectic has an endothermic peak before decomposition, the melting point of the TBR-CAM eutectic is 140.19℃, and there is a strong endotherm at 197.81℃, and the weight loss is about 30% before 248℃. The melting points of the carboxylic acid ligands and their corresponding eutectics are shown in Table 3.
[0078] Table 3 Melting points of carboxylic acid ligands and their corresponding cocrystals
[0079]
[0080] Embodiment 14
[0081] FT-IR spectra were recorded using a Vertex 70 FTIR spectrometer (Germany) with KBr pellets in the range of 4000 to 500 cm -1 Within 4cm -1 The resolution of the measurement is
[0082] FT-IR spectra of TBR and cocrystal are shown in Fig. 9 As shown. The formation of hydrogen bonds will slightly change the bond length and bond energy of each covalent bond, which can be represented by the displacement of characteristic peaks in the infrared spectrum. The XH bonds on the donor are greatly affected, and the red shift of the infrared spectrum is related to the strength of hydrogen bond formation. The C=O, C=N and NH stretching vibration peaks of TBR (1547.72, 1690.16 and 3152.81 cm -1 ) for TBR-p-COA shifted to 1601.11, 1693.51 and 3116.79 cm -1 For TBR-2,4,6-TRM, it moves to 1530.65, 1711.24 and 3207.07 cm -1 , for TBR-GAL·2H2O, they shifted to 1558.66, 1693.49, and 3296.04 cm -1 , for TBR-GAL·4H2O, moved to 1600.40, 1694.85, and 3296.96 cm -1 , for TBR-CAM, moved to 1548.06, 1689.89 and 3158.63cm -1 , for TBR-1-H-2-NA shifted to 1574.42, 1687.04 and 3138.66 cm -1 , at TBR-SCA to 1548.52, 1694.27 and 3116.73cm -1 , which can be attributed to the formation of intermolecular hydrogen bonds.
[0083] Embodiment 15
[0084] TBR, TBR-p-COA, TBR-2,4,6-TRM, TBR-GAL·2H2O, TBR-GAL·4H2O, TBR-SCA, TBR-CAM and TBR-1-H-2-NA were ground and sieved through a standard sieve for solubility experiments. The solubility of TBR, TBR-p-COA, TBR-2,4,6-TRM, TBR-GAL·2H2O, TBR-GAL·4H2O, TBR-SCA, TBR-CAM and TBR-1-H-2-NA in water was determined as follows: an excess of each powder sample was added to 100 mL of ultrapure water and stirred at 25°C for 24 h; the slurry was filtered and appropriately diluted for HPLC measurement; the solubility measurement was performed three times. Solubility experiments were conducted in simulated intestinal fluid in phosphate buffered saline (PBS): an excess of each powder sample was added to 30 mL of PBS and stirred at 37°C for 24 h. The slurry was filtered through a 0.22 μm filter at a predetermined time and appropriately diluted for HPLC determination, with three parallel determinations.
[0085] The equilibrium solubilities of TBR and TBR-2,4,6-TRM, TBR-p-COA, TBR-GAL·2H2O, TBR-GAL·4H2O, TBR-SCA, TBR-CAM and TBR-1-H-2-NA in 25℃ water and 37℃ PBS simulated intestinal fluid are shown in Table 4. Except for TBR-1-H-2-NA, the solubility of the other six cocrystals or hydrates in water is higher than that of TBR, so the six cocrystals effectively improve the solubility of TBR in water. The solubility of TBR-GAL·4H2O in water is nearly twice that of TBR. The solubility of TBR-p-COA in water is slightly higher than that of TBR. The solubility of TBR-2,4,6-TRM and TBR-GAL·2H2O in water is 1.3 times that of TBR. Compared with water, the equilibrium solubility ratio of TBR and its cocrystals in PBS is greatly increased. The solubility of TBR-2,4,6-TRM, TBR-p-COA, TBR-GAL·2H2O and TBR-GAL·4H2O in PBS is about 2–4 times the equilibrium solubility in water. The equilibrium solubility of TBR and p-COA cocrystal in PBS even reaches 1.997 mg / ml, which is 4.3 times that in water and 3 times that of TBR in PBS. In PBS containing 37°C simulated intestinal fluid, the equilibrium solubility of TBR-2,4,6-TRM, TBR-p-COA, TBR-GAL·2H2O and TBR-GAL·4H2O increased significantly. The formation of cocrystal can effectively increase the solubility of TBR.
[0086] Table 4 Equilibrium solubility of TBR and cocrystals in 25℃ water and 37℃ PBS simulated intestinal fluid
[0087]
[0088] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.
Claims
1. A theobromine carboxylic acid cocrystal, characterized in that: The theobromine carboxylic acid eutectic is formed by theobromine and carboxylic acid, wherein the carboxylic acid is one of p-coumaric acid, 2,4,6-trihydroxybenzoic acid and gallic acid; The method for preparing theobromine carboxylic acid cocrystal comprises a solvent-assisted grinding method or a solvent volatilization method; The solvent-assisted grinding method specifically comprises: mixing theobromine, carboxylic acid and acetone in a ball mill, and obtaining theobromine carboxylic acid cocrystal after ball milling; The solvent evaporation method specifically comprises: mixing theobromine and carboxylic acid and dissolving them in a solvent, and evaporating the solvent to obtain theobromine carboxylic acid cocrystal; The theobromine carboxylic acid eutectic is specifically: TBR-2,4,6-TRM, TBR-p-COA, TBR-GAL·4H2O; The crystallographic data of TBR-2,4,6-TRM are as follows: the monomer structural formula is C7H8N4O2·C7H6O5, and the monomer chemical formula is C 14 H 14 N4O7, the monomer relative molecular mass is 350.29, the crystal system is monoclinic, the space group is P21 / c, and the Hall group is a is b is c is α is 90 degrees, β is 95.122 (2) degrees, γ is 90 degrees, and the volume is The crystallographic data of TBR-p-COA are as follows: the monomer structural formula is C7H8N4O2·C9H8O3, and the monomer chemical formula is C 16 H 16 N4O5, the monomer relative molecular mass is 344.33, the crystal system is triclinic, and the space group is Hall Group a is b is c is α is 80.367(4)deg, β is 69.633(4)deg, γ is 67.650(5)deg, and the volume is The crystallographic data of TBR-GAL·4H2O are as follows: the monomer structural formula is C7H8N4O2·C7H6O5·4H2O, and the monomer chemical formula is C 14 H 22 N4O 11 The relative molecular mass of the monomer is 422.36, the crystal system is monoclinic, the space group is C2 / c, and the Hall group is a is b is c is α is 90 degrees, β is 104.662 (3) degrees, γ is 90 degrees, and the volume is 2. The theobromine carboxylic acid cocrystal according to claim 1, characterized in that The molar ratio of theobromine to carboxylic acid is 1:1 or 2:
1.
3. The preparation method according to claim 1, characterized in that: The molar ratio of theobromine to carboxylic acid is 1-2:
1.
4. The preparation method according to claim 1, characterized in that: The ball milling frequency is 15-30 Hz, and the ball milling time is 30-60 min.
5. The preparation method according to claim 1, characterized in that: The solvent includes one or a mixture of methanol, ethanol, water and acetonitrile.
6. Use of the theobromine carboxylic acid cocrystal according to any one of claims 1 to 2 in the preparation of a theobromine-containing medicine or food.
